 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Vandetanib , Etoposide |
 |
 |
 |
 |
Phase: |
 |
Phase 1 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1940
NCT00613223
|
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
09/05/2009 |
 |
 |
 |
 |
Tumor Types: |
 |
Anaplastic Astrocytoma Glioblastoma Multiforme Gliosarcoma Oligodendroglioma High Grade |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy. |
 |
 |
 |
 |
Contact: |
 |
The Brain Tumor Center at Duke Henry Friedman, MD Contact: Dr. Henry S. Friedman Rm 047 Baker House, Hospital South Trent Drive Durham, NC 27710- Phone:(919)684-5301 Fax: (919)684-6674 Click here to send an email Website: www.cancer.duke.edu/btc |
 |
 |
|
|